Table 4.
Strategies to improve gene transfer efficacy of nonviral vectors.
Barriers | Functional moieties | Approaches | Materials/molecules used |
---|---|---|---|
Extracellular stability | Carrier molecules, hydrophobic moiety | DNA condensation protects from nucleases steric stability achieved by surface charge shielding | Protamine, lipids, gelation, PEGylation |
Internalization | Targeting ligands | Receptor-mediated endocytosis | Transferrin, EGF, antibodies, RGD |
Intracellular trafficking | Endosomal disruptive agent | Escape from endosomes and unpacking by proton sponge effect | PEI, DOPE |
Nuclear entry | Nuclear localization signal | Nuclear entry | Tat, ReV |
DNA: Deoxyribonucleic acid; EGF: epidermal growth factor; RGD: arginyl-glycylaspartic acid; DOPE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, Tat: HIV-1-transactivating protein; ReV: HIV-1 Rev protein; PEI: polyethyleneimine.